Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients

This publication has 20 references indexed in Scilit:

• Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients
  FEMS Immunology & Medical Microbiology, 2006
• Nevirapine (NVP) Resistance in Women with HIV‐1 Subtype C, Compared with Subtypes A and D, after the Administration of Single‐Dose NVP
  The Journal of Infectious Diseases, 2005
• Characterization of a Subtype D Human Immunodeficiency Virus Type 1 Isolate That Was Obtained from an Untreated Individual and That Is Highly Resistant to Nonnucleoside Reverse Transcriptase Inhibitors
  Journal of Virology, 2004
• Genetic diversity of HIV in Africa
  AIDS, 2003
• Polymorphism in Protease and Reverse Transcriptase and Phenotypic Drug Resistance of HIV-1 Recombinant CRF02_AG Isolates From Patients With No Prior Use of Antiretroviral Drugs in Abidjan, Côte d'Ivoire
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug‐Naive Patients Treated with Protease Inhibitor–Based Therapy
  The Journal of Infectious Diseases, 2001
• Travel and the Introduction of Human Immunodeficiency Virus Type 1 Non‐B Subtype Genetic Forms into Western Countries
  Clinical Infectious Diseases, 2001
• Protease sequences from HIV-1 group M subtypes A???H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide
  AIDS, 2000
• HIV-1 Nomenclature Proposal
  Science, 2000
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
  Nucleic Acids Research, 1994